Figure 4.
Nerve conduction velocity on day 21 posttreatment. The injured group showed a significant decrease in nerve conduction velocity (cm/seconds) compared to the sham group. All treated groups showed an increase in the nerve conduction velocity (p < 0.05 vs. ∗sham, #injured, @adipose tissue-derived mesenchymal stem cells (ADMSCs), ^pregabalin, or $combined). The combined treatment was not significantly different than ADMSCs or pregabalin alone (p > 0.05).